Sulfamethoxazole/trimethoprim resistance overcall by VITEK® 2 and BD Phoenix™ in community-associated MRSA and MSSA

被引：3
|
作者：
Coombs, Geoffrey W. [1 ,2 ]
Mowlaboccus, Shakeel [3 ]
Daley, Denise [2 ]
Lee, Terence [1 ]
Pearson, Julie [2 ]
Pang, Stanley [1 ,2 ]
Robinson, James O. [1 ,2 ,4 ]
机构：
[1] Murdoch Univ, Antimicrobial Resistance & Infect Dis Lab, Sch Vet Life Sci, Murdoch, WA, Australia
[2] Fiona Stanley Hosp, PathWest Lab Med WA, Murdoch, WA, Australia
[3] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Sch Biomed Sci, Perth, WA, Australia
[4] Royal Perth Hosp, Dept Microbiol & Infect Dis, Perth, WA, Australia
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2019年 / 74卷 / 12期
关键词：
D O I：
10.1093/jac/dkz361
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：3639 / 3641
页数：3
相关论文
共 27 条
  • [1] Trimethoprim-Sulfamethoxazole or Clindamycin for Community-Associated MRSA (CA-MRSA) Skin Infections
    Frei, Christopher R.
    Miller, Monica L.
    Lewis, James S., II
    Lawson, Kenneth A.
    Hunter, Jonathan M.
    Oramasionwu, Christine U.
    Talbert, Robert L.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2010, 23 (06) : 714 - 719
  • [2] Re: Trimethoprim-sulfamethoxazole or Clindamycin for Community-Associated MRSA (CA-MRSA) Skin Infections
    Khawcharoenporn, Thana
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2011, 24 (03) : 331 - 331
  • [3] Response: Re: Trimethoprim-sulfamethoxazole or Clindamycin for Community-Associated MRSA (CA-MRSA) Skin Infections
    Frei, Christopher R.
    Miller, Monica L.
    Forcade, Nicolas A.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2011, 24 (03) : 332 - 333
  • [4] Community-associated MRSA - Resistance and virulence converge
    Chambers, HF
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14): : 1485 - 1487
  • [5] Glycopeptide and daptomycin resistance in community-associated MRSA in the UK
    A. Kirby
    C. Edwards
    C. M. Broughton
    N. J. Williams
    Infection, 2011, 39 : 277 - 279
  • [6] Glycopeptide and daptomycin resistance in community-associated MRSA in the UK
    Kirby, A.
    Edwards, C.
    Broughton, C. M.
    Williams, N. J.
    INFECTION, 2011, 39 (03) : 277 - 279
  • [7] Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage
    Rossi, Flavia
    Diaz, Lorena
    Wollam, Aye
    Panesso, Diana
    Zhou, Yanjiao
    Rincon, Sandra
    Narechania, Apurva
    Xing, Galen
    Di Gioia, Thais S. R.
    Doi, Andre
    Tran, Truc T.
    Reyes, Jinnethe
    Munita, Jose M.
    Carvajal, Lina P.
    Hernandez-Roldan, Alejandra
    Brandao, Denise
    van der Heijden, Inneke Marie
    Murray, Barbara E.
    Planet, Paul J.
    Weinstock, George M.
    Arias, Cesar A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (16): : 1524 - 1531
  • [8] Determination of the mutant selection window for clindamycin, doxycycline, linezolid, moxifloxacin and trimethoprim/sulfamethoxazole against community-associated meticillin-resistant Staphylococcus aureus (MRSA)
    Allen, George P.
    Deshpande, Lalitagauri M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 35 (01) : 45 - 49
  • [9] BD Phoenix and Vitek 2 Detection of mecA-Mediated Resistance in Staphylococcus aureus with Cefoxitin
    Junkins, Alan D.
    Lockhart, Shawn R.
    Heilmann, Kristopher P.
    Dohrn, Cassie L.
    Von Stein, Diana L.
    Winokur, Patricia L.
    Doern, Gary V.
    Richter, Sandra S.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (09) : 2879 - 2882
  • [10] Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus
    Leonard, Steven N.
    Kaatz, Glenn W.
    Rucker, Latoyia R.
    Rybak, Michael J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1305 - 1310
123